Research Report on Pay TV, Passwords, and Piracy
/
Date20 Apr 2018
Raipur, India, April 20, 2018 (GLOBE NEWSWIRE) — Report Sellers has added a new market research report on “Pay TV, Passwords, and Piracy” to its... Read More →
Three new Elev8 Hemp products enter brick and mortar
/
Date20 Apr 2018
ORLANDO, Fla., April 20, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire – Elev8 Brands, Inc. (OTC Pink:VATE), a holding company focused on the commercial... Read More →
WestRock Announces Quarterly Dividend of $0.43 Per Share
/
Date20 Apr 2018
ATLANTA, April 20, 2018 (GLOBE NEWSWIRE) — The Board of Directors of WestRock Company (NYSE:WRK) today declared a regular quarterly dividend of $0.43 per share... Read More →
Ceapro Inc. Reports 2017 Financial Results
/
Date20 Apr 2018
EDMONTON, Alberta, April 20, 2018 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization... Read More →
Star Bulk Announces the Acquisition of 16 Vessels from Augustea Atlantica & York Capital Management
/
Date20 Apr 2018
ATHENS, Greece, April 20, 2018 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq:SBLK), today announced that it has agreed to... Read More →
CPSI to Broadcast Its First Quarter 2018 Conference Call Live on the Internet
/
Date20 Apr 2018
MOBILE, Ala., April 19, 2018 (GLOBE NEWSWIRE) — CPSI (NASDAQ: CPSI), a community healthcare solutions company, today announced that it will release its financial results... Read More →
Apstiprināti New Hanza Capital, AS auditētie rezultāti par 2017. gadu
/
Date20 Apr 2018
Rīga, Latvija, 2018-04-20 14:28 CEST (GLOBE NEWSWIRE) — New Hanza Capital, AS valde un padome apstiprināja auditētos New Hanza Capital, AS konsolidētos un sabiedrības atsevišķos... Read More →
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
/
Date20 Apr 2018
NEW YORK and CLEVELAND, April 20, 2018 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies... Read More →
Inpixon Launches Public Offering in an Effort to Satisfy NASDAQ’s Stockholders’ Equity Requirement
/
Date20 Apr 2018
PALO ALTO, Calif., April 19, 2018 (GLOBE NEWSWIRE) — Inpixon (NASDAQ:INPX), (the “Company” or “Inpixon”), a leading indoor positioning and data analytics company, today announced the... Read More →